Evidence map›Paper›PMID 33591242›Full record

ArticleAmerican journal of respiratory cell and molecular biology2021

Notch3: A New Culprit in Fibrotic Lung Disease.

Prathibha R Gajjala, Satish K Madala

Abstract readEditorialComment
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Examining the contribution of Notch signaling to lung disease development.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Prathibha R GajjalaDepartment of Pediatrics University of Cincinnati Cincinnati, Ohio and.ORCID 0000-0001-5491-4148
Satish K MadalaDepartment of Pediatrics University of Cincinnati Cincinnati, Ohio and.ORCID 0000-0002-6042-5321

Funding

WT1 REGULATION OF PULMONARY FIBROSISR01HL134801 · NHLBI · UNIVERSITY OF CINCINNATI · PI MADALA, SATISH K · 2017 to 2025
$3.9M
Sox9 Regulation of Fibroblast Activation and Pulmonary FibrosisR01HL157176 · NHLBI · UNIVERSITY OF CINCINNATI · PI MADALA, SATISH K · 2021 to 2025
$2.5M
IL-31 Regulation of Immunopathology in Pulmonary FibrosisR21AG059533 · NIA · CINCINNATI CHILDRENS HOSP MED CTR · PI MADALA, SATISH K · 2018 to 2019
$452k
NHLBI NIH HHS R01 HL134801NHLBI NIH HHS R01 HL157176NIA NIH HHS R21 AG059533
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Pulmonary FibrosisHumansLungReceptor, Notch3NOTCH3 protein, humanReceptor, Notch3

Identifiers

PMID33591242
PMCPMC8008798

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.